Vaccines News ArticlesExcerpts of key news articles on vaccines
A monkey virus linked to human cancers may have contaminated the oral polio vaccine for years after the U.S. government ordered manufacturers to remove it. The Chronicle reported last week that the simian virus SV40 had contaminated early polio vaccine given to millions of Americans. When health officials discovered in 1961 that SV40 caused malignant tumors in lab animals, they ordered the virus eliminated from all future vaccine. But internal memos from Lederle Laboratories, the chief producer of polio vaccine in the United States, indicate SV40 may not have been completely removed. According to one memo, SV40 was found in three of 15 lots of the oral vaccine seven months after the federal directive was issued in March 1961. Lederle released the contaminated vaccine to the public anyway, the memo shows. Scientists discovered SV40 in the Salk polio vaccine in 1960. By then as many as 30 million Americans had been given injections of the SV40-tainted polio vaccine, which was first licensed in 1955. In recent years more than 60 scientific studies have found SV40 in rare human brain, bone and lung-related cancers, the same kinds of tumors the virus caused in laboratory animals. Some scientists believe SV40 may play a role in causing those cancers. The Lederle documents, which were obtained by Philadelphia attorney Stanley Kops in litigation not related to SV40, raise the possibility the virus might have been transmitted by contaminated oral vaccine, licensed for production in 1962.
Note: There are numerous major problems with how vaccines are monitored and developed, yet the media largely fails to address this major issue. For many powerful reports from reliable sources on the dangers of vaccines, click here. For lots more, click here and here.
A simian virus known as SV40 has been associated with a number of rare human cancers. This same virus contaminated the polio vaccine administered to 98 million Americans from 1955 to 1963. Federal health officials see little reason for concern. A growing cadre of medical researchers disagree. A breakthrough in the war against polio had come in the early 1950s, when Jonas Salk took advantage of a new discovery: monkey kidneys could be used to culture the abundant quantities of polio virus necessary to mass-produce a vaccine. But there were problems with the monkey kidneys. In 1960 Bernice Eddy, a government researcher, discovered that when she injected hamsters with the kidney mixture on which the vaccine was cultured, they developed tumors. Eddy's superiors tried to keep the discovery quiet, but Eddy presented her data at a cancer conference in New York. She was eventually demoted, and lost her laboratory. The cancer-causing virus was soon isolated by other scientists and dubbed SV40, because it was the fortieth simian virus discovered. Alarm spread through the scientific community as researchers realized that nearly every dose of the vaccine had been contaminated. In 1961 federal health officials ordered vaccine manufacturers to screen for the virus and eliminate it from the vaccine. Worried about creating a panic, they kept the discovery of SV40 under wraps and never recalled existing stocks. For two more years millions of additional people were needlessly exposed -- bringing the total to 98 million Americans from 1955 to 1963.
Note: This fascinating report on modern research into SV40's role in human cancers is well worth reading in its entirety at the link above. It is most strange that the CDC posted a webpage stating "it has been estimated that 10–30 million Americans could have received an SV40 contaminated dose of vaccine" and much more, but the webpage was then taken down. Using the Internet Archive, you can still see the revealing page that has been removed at this link.
The announcement this week that a cheap, easy-to-make coronavirus vaccine appeared to be up to 90 percent effective was greeted with jubilation. But since unveiling the preliminary results, AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants, adding to questions about whether the vaccine's apparently spectacular efficacy will hold up under additional testing. Scientists and industry experts said the error and a series of other irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results. The regimen that appeared to be 90 percent effective was based on participants receiving a half dose of the vaccine followed a month later by a full dose; the less effective version involved a pair of full doses. AstraZeneca disclosed in its initial announcement that fewer than 2,800 participants received the smaller dosing regimen, compared with nearly 8,900 participants who received two full doses. Moncef Slaoui, the head of Operation Warp Speed, the U.S. initiative to fast-track coronavirus vaccines, noted another limitation in AstraZeneca's data. On a call with reporters, he suggested that the participants who received the half-strength initial dose had been 55 years old or younger. The fact that the initial half-strength dose wasn't tested in older participants, who are especially vulnerable to Covid-19, could undermine AstraZeneca's case to regulators that the vaccine should be authorized for emergency use.
Note: Learn in this revealing article how vaccine trials are rigged. This article spells out how vaccine makers are above the law and face no consequences for damage from vaccines. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.
Two former Merck & Co Inc scientists accusing the drugmaker of falsifying tests of its exclusive mumps vaccine said in a court filing on Monday that Merck is refusing to respond to questions about the efficacy of the vaccine. Attorneys at Constantine Cannon, who represent the scientists, asked U.S. Magistrate Judge Lynne Sitarski of the Eastern District of Pennsylvania to compel Merck to respond to their discovery request, which asks the company to give the efficacy of the vaccine as a percentage. Instead of answering the question ... Merck has been consistently evasive, using “cut-and-paste” answers saying it cannot run a new clinical trial to determine the current efficacy, and providing only data from 50 years ago. The two scientists, Stephen Krahling and Joan Wlochowski, filed their whistleblower lawsuit in 2010 claiming Merck, the only company licensed by the Food and Drug Administration to sell a mumps vaccine in the United States, skewed tests of the vaccine by adding animal antibodies to blood samples. As a result, they said, Merck was able to produce test results showing that the vaccine was 95 percent effective, even though more accurate tests would have shown a lower success rate. The plaintiffs said these false results kept competitors from trying to produce their own mumps vaccines, since they were unable to match the effectiveness Merck claimed. The case is United States ex rel Krahling et al v. Merck & Co Inc, U.S. District Court, Eastern District of Pennsylvania, No. 10-4374.
Note: Why didn't this get reported widely? A search reveals no major media other than Reuters and WSJ covered this. This article in a local paper states the two whistleblowers were threatened by Merck with jail if they went public with this. It also says all students in a Syracuse University mumps outbreak had been properly vaccinated. This excellent article gives a 2019 update and reveals how the vaccines caused injury in a very high percentage of cases. For more, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Two health care workers at the same hospital in Alaska developed concerning reactions just minutes after receiving Pfizer's coronavirus vaccine this week, including one staff member who was to remain hospitalized until Thursday. The first worker, a middle-aged woman who had no history of allergies, had an anaphylactic reaction that began 10 minutes after receiving the vaccine. [After treatment] her symptoms subsided but then re-emerged, and she was treated with steroids and an epinephrine drip. When doctors tried to stop the drip, her symptoms re-emerged yet again, so the woman was moved to the intensive care unit. The second worker received his shot on Wednesday and developed eye puffiness, lightheadedness and a scratchy throat 10 minutes after the injection. He was taken to the emergency room and treated. The worker was back to normal within an hour and released. The hospital ... administered 144 total doses. The Alaska woman's reaction was believed to be similar to the anaphylactic reactions two health workers in Britain experienced after receiving the Pfizer-BioNTech vaccine last week. Like her, both recovered. Pfizer's trial did not find any serious adverse events caused by the vaccine, although many participants did experience aches, fevers and other side effects. [The CDC] has recommended that the vaccine be administered in settings that have supplies, including oxygen and epinephrine, to manage anaphylactic reactions.
Note: Does this sound like a safe vaccine? Remember that billions of dollars are involved here and Pfizer in the past was fined $2.3 billion dollars for illegal processes. How much can we trust them? More in this great article. And watch a video of a nurse fainting while being interviewed on TV minutes after getting the vaccine. For more, see concise summaries of deeply revealing news articles on problems with the coronavirus vaccines from reliable major media sources. Then explore the excellent, reliable resources provided in our Coronavirus Information Center.
Ask people to name Pfizer's best-selling product and many would opt for one of its most famous drugs: Viagra, for erectile dysfunction, or Lipitor, to reduce high cholesterol. But they would all be wrong. The top-seller is not a drug but a vaccine: Prevnar, which prevents pneumonia, meningitis and other infections caused by pneumococcus bacteria. Prevnar generated revenues of $6.25bn last year – almost three times as much as Viagra. This was up 40 per cent from the year before, after the expert panel that advises on US vaccine policy recommended its use in over-65s as well as in children. Pfizer is one of just four pharma groups with large vaccines operations. The others are GlaxoSmithKline of the UK, Sanofi of France and Merck of the US. All four reported stronger sales growth in vaccines than in pharmaceuticals last year and operating margins were comparable with pharma at around 25-30 per cent. Pricing remains a sensitive topic, however, especially in the developing world. MĂ©decins Sans FrontiĂ¨res, the health charity, last month launched a challenge against Pfizer's patent on Prevnar in a bid to allow Indian companies to produce the vaccine cheaper. Manica Balasegaram, executive director of the MSF Access Campaign, says it could be produced in India for $6 per child, compared with Pfizer's reduced $10 price. Critics argue that consolidation in the industry has left too few companies, developing too few vaccines – and that those that do exist tend to be aimed at rich countries.
Note: Read this eye-opening article showing how powerful financial interests control the public narrative about vaccines. For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Pfizer chairman Albert Bourla told NBC's Dateline host Lester Holt that the pharmaceutical company was "not certain" if the vaccine prevented the coronavirus from being transmitted, saying: "This is something that needs to be examined." In a prime-time special titled "Race for a Vaccine" ... Holt questioned Bourla and other individuals involved in the development and distribution of the vaccine. In November, Pfizer announced that its vaccine candidate had been shown to be more than 90% effective at preventing COVID-19 and has applied for emergency use authorization from the Food and Drug Administration (FDA). The U.K. became the first country to approve Pfizer's vaccine this week with the first round of immunizations expected to roll out next week. In August, Canada signed a deal with Pfizer for 20 million doses of the vaccine. In a list of interview highlights released before the special, Holt asked Bourla: "Even though I've had the protection, am I still able to transmit it to other people?" "I think this is something that needs to be examined. We are not certain about that right now with what we know," Bourla responded.
Note: An MSN article reported that a 41-year-old Portuguese health worker died two days after getting the Pfizer vaccine, but then removed the article. Learn more about this death in this article. A Florida doctor also died after receiving the vaccine. This CDC report states "December 14–23, 2020, monitoring â€¦ detected 21 cases of anaphylaxis after administration of a reported 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine." For more, explore the excellent, reliable resources provided in our Coronavirus Information Center.
In the coming months, Linda Thomas-Greenfield, President Joe Biden's ambassador to the United Nations, will hear from a growing chorus of developing nations about the foundering efforts to distribute the coronavirus vaccine globally. The nations, many of which have not even begun vaccinating their populations, are demanding that the U.S. support proposals to temporarily waive certain patent and intellectual property rights so that generic coronavirus vaccines can be produced. The proposals have been fiercely opposed by American drugmakers, including Pfizer. ASG ... represents Pfizer. Many leading figures in Biden's administration, including key White House advisers, State Department leaders, and health care officials have financial stake in or professional ties to vaccine manufacturers, which are now lobbying to prevent policies that would cut into future profits over the vaccine. ASG in particular has unusual amounts of sway in the Biden administration. State Department officials Victoria Nuland, Wendy Sherman, Uzra Zeya, and Molly Montgomery previously worked at ASG, as did Philip Gordon, Vice President Kamala Harris's national security adviser. The pharmaceutical industry, in a bid to shield an expected financial windfall, has pressed the Biden administration not only to oppose the waiver, but also to impose trade-related sanctions on countries that back [a] proposal or move to manufacture coronavirus vaccines without permission from patent holders.
At least four candidates are near the finish line in the U.S. coronavirus vaccine race. A key point to note, however, is that the vaccine isn't an end-all solution to the pandemic. That's in large part because any inoculations developed now are focused on simply preventing symptoms from arising, rather than blocking out the virus altogether. The latter goal is a secondary endpoint, according to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "The primary thing you want to do is that if people get infected, prevent them from getting sick, and if you prevent them from getting sick, you will ultimately prevent them from getting seriously ill," Fauci said. "What I would settle for, and all of my colleagues would settle for, is the primary endpoint to prevent clinically recognizable disease," he said. That level of protection would be the ultimate goal to diffusing the crisis, but is hard to do with companies facing an immediate demand for some sort of solution. While no vaccine is 100% effective, having a majority of the population inoculated and higher percentages of efficacy is the best to hope for. The U.K. is looking at challenge trials, which intentionally infect a smaller group of participants with the virus in an effort to test a vaccine's or treatment's efficacy. Fauci said the U.S. is not anticipating such a move because the rate of spread is so high in the country that it's sufficient enough of an environment to test the vaccine.
Note: This Bloomberg article further shows the vaccines are not designed to stop the virus. Why is the media not doing a better job of informing the public about this. Read also this CNBC article titled "Dr. Fauci says masks, social distancing will still be needed after a Covid-19 vaccine." For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccine issues from reliable major media sources.
Moderna, Pfizer, AstraZeneca, and Johnson & Johnson are leading candidates for the completion of a Covid-19 vaccine likely to be released in the coming months. These companies have published their vaccine trial protocols. Close inspection of the protocols raises surprising concerns. These trials seem designed to prove their vaccines work, even if the measured effects are minimal. Prevention of infection is not a criterion for success for any of these vaccines. In fact, their endpoints all require confirmed infections and all those they will include in the analysis for success, the only difference being the severity of symptoms between the vaccinated and unvaccinated. Measuring differences amongst only those infected by SARS-CoV-2 underscores the implicit conclusion that the vaccines are not expected to prevent infection, only modify symptoms of those infected. We all expect an effective vaccine to prevent serious illness if infected. Three of the vaccine protocols - Moderna, Pfizer, and AstraZeneca - do not require that their vaccine prevent serious disease only that they prevent moderate symptoms which may be as mild as cough, or headache. A vaccine must significantly or entirely reduce deaths from Covid-19. None list mortality as a critical endpoint.
Note: Read also this article in BMJ (British Medical Journal) titled "Will covid-19 vaccines save lives? Current trials aren't designed to tell us." And this CNBC article is titled "Dr. Fauci says masks, social distancing will still be needed after a Covid-19 vaccine." For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccine issues from reliable major media sources.
The World Health Organization says Zambia has reported its first local case of polio since 1995, in a 2-year-old boy paralyzed by a virus derived from the vaccine. In a report this week, WHO said the case was detected on the border with Congo, which has reported 37 cases of polio traced to the vaccine this year. The U.N. health agency said there is no established link between the Zambia case and the ongoing Congo outbreak but said increased surveillance and vaccination efforts are needed, warning that “there is a potential for international spread.” In rare cases, the live virus in oral polio vaccine can mutate into a form capable of sparking new outbreaks. Nine African countries are currently battling polio epidemics linked to the vaccine as WHO and partners struggle to keep their efforts to eradicate polio on track. Elsewhere, cases have been reported in China, Myanmar and the Philippines. On Thursday, WHO and partners are expected to announce they have rid the world of type 3 polio virus. There are three types of polio viruses. Type 2 was eliminated years ago. That now leaves only type 1. But that refers only to polio viruses in the wild. Type 2 viruses continue to cause problems since they are still contained in the oral polio vaccine and occasionally evolve into new strains responsible for some vaccine-derived outbreaks. The global effort to eradicate polio was launched in 1988 and originally aimed to wipe out the potentially fatal disease by 2000.
Note: See an NPR article titled "Mutant Strains Of Polio Vaccine Now Cause More Paralysis Than Wild Polio." For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
A leading cancer expert, who was described as a "pioneer" in his field by Prince William, has died suddenly after receiving a routine yellow fever vaccination. Martin Gore, 67, died Thursday morning after receiving the vaccine. Professor Mel Greaves from the Institute of Cancer Research, described Gore as "a force of nature, very energetic, clear-thinking and compassionate." Gore's death casts light on the heightened risk associated with the yellow fever vaccine and the over-60 demographic. Typical side effects of the vaccine include headaches, muscle pain, mild fever and soreness at the injection site, according to the NHS. However, the vaccinations can, in rare circumstances, cause more severe side effects, including allergic reactions and problems affecting the brain or organs. The NHS estimates that these reactions occur less than 10 times for every million doses. The WHO reported that all cases of viscerotropic disease -- a rare but dangerous side effect of yellow fever vaccinations where an illness similar to wild-type yellow fever proliferates in multiple organs -- have occurred in primary vaccines, starting two to five days after vaccination. The Centers for Disease Control and Prevention -- the US government's health protection agency -- warns that viscerotropic disease can lead to multiple organ dysfunction syndrome or multi-organ failure and death in close to 60% of cases.
Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccine safety from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
British drug giant GlaxoSmithKline has finally admitted that thousands of babies in this country were inoculated with a batch of toxic whooping cough vaccines in the 1970s. Some experts believe that these Trivax vaccines - which had not passed critical company safety tests - may have caused permanent brain damage and even fatalities in young children. In 1992, the family of an Irish boy, Kenneth Best, who suffered brain damage from one of these toxic vaccines, was awarded Ł2.7 million in compensation by the Irish Supreme Court. The boy's family finally won this historic case after his mother Margaret made a startling find when sifting through tens of thousands of company documents. She discovered that the Trivax vaccine used on her son, from a batch numbered 3,741, had been released by the company despite it having failed to pass a critical safety test. Documents revealed that the 60,000 individual doses within this batch were known to be 14 times more potent than normal. Last year an investigation by The Observer found evidence to suggest that vaccines from this faulty batch ... had also been used in Britain. Liberal Democrat MP Norman Baker raised questions in the House of Commons, asking whether vaccines from this batch had been given to British babies. Then Health Minister Yvette Cooper wrote to the company asking for information. Now, almost a year later, GlaxoSmithKline has replied that it is 'highly probable' the toxic batches had been used in Britain.
Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccine risks from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
Pfizer expects to sell $15 billion worth of Covid-19 vaccines in 2021. That would make it the second-highest revenue-generating drug anytime, anywhere, according to industry reports. The maker of the first Covid-19 vaccine to be approved for use in advanced markets has released its earning forecasts for 2021 today. Pfizer expects to earn between $59 billion and $61 billion - up from $42 billion it made in 2020. Sales of the vaccine are set to bring in about a fourth of Pfizer's total revenue this year. That would be nearly as much as its three best-selling products combined. The company is expecting profit margins for the vaccine to be between 25% and 30% which means profits from the vaccine could be around $4 billion. All of Pfizer's costs and profits from the vaccine are split evenly with BioNTech, the biotech company that helped develop the treatment. There are is only one drug in the world that sells more - Humira, a prescription medication for arthritis. Pfizer plans on selling 2 billion doses of the vaccine this year, but that demand should subside in coming years so the revenue of Covid-19 vaccine won't be stable, Pfizer's CEO Albert Bourla said on an call with analysts and investors. The company expects to continue profiting from it by selling booster doses, including ones required to shield against new variants of the virus, Bourla said. Further, Pfizer is pursuing more avenues to employ the mRNA technology underlying the vaccine, including a flu vaccine and other therapeutic applications.
Note: Read more in this revealing Reuters article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma profiteering from reliable major media sources.
On June 26, a small South San Francisco company called Vaxart made a surprise announcement: A coronavirus vaccine it was working on had been selected by the U.S. government to be part of Operation Warp Speed, the flagship federal initiative to quickly develop drugs to combat Covid-19. The race is on to develop a coronavirus vaccine, and some companies and investors are betting that the winners stand to earn vast profits from selling hundreds of millions – or even billions – of doses to a desperate public. Across the pharmaceutical and medical industries, senior executives and board members ... are making millions of dollars after announcing positive developments, including support from the government, in their efforts to fight Covid-19. After such announcements, insiders from at least 11 companies – most of them smaller firms whose fortunes often hinge on the success or failure of a single drug – have sold shares worth well over $1 billion since March. Senior officials appear to be pouncing on opportunities to cash out. And some companies have awarded stock options to executives shortly before market-moving announcements about their vaccine progress. Some companies are attracting government scrutiny for ... using their associations with Operation Warp Speed as marketing ploys. Vaxart's news release declared: "Vaxart's Covid-19 Vaccine Selected for the U.S. Government's Operation Warp Speed." But Vaxart is not among the companies selected to receive significant financial support from Warp Speed.
Note: MSN strangely removed this article a few days after posting it. A similar article by the New York Times titled "The race for a coronavirus vaccine is making some corporate insiders very rich" is available here. For more along these lines, see concise summaries of deeply revealing news articles on big Pharma corruption and the coronavirus from reliable major media sources.
Louis Pasteur, one of the legendary figures in the history of science, lied about his research, stole ideas from a competitor and was deceitful in ways that would now be regarded as scientific misconduct if not fraud, according to a revisionist history published this month. "The Private Science of Louis Pasteur," by Dr. Gerald L. Geison of Princeton University, is based on an examination of Pasteur's 102 laboratory notebooks. Pasteur ... tried to reduce the virulence of microbes by exposing them to oxygen in order to make them suitable for vaccination. But in developing a vaccine against anthrax ... Pasteur adapted a method he had used a year earlier to produce a vaccine against chicken cholera. To head off competitors, Pasteur had purposely withheld reporting the simple method he used to prepare the chicken cholera vaccine. Pasteur impulsively accepted a public challenge to carry out the world's first public trial of any experimental vaccine. Pasteur's assistants injected his formula into 25 sheep, left another 25 unprotected and then injected all 50 with virulent anthrax bacteria. Only the vaccinated sheep survived. But, the notebooks show, Pasteur lied when he suggested publicly that his dramatically successful vaccine had been developed by exposing anthrax bacteria to oxygen. In fact he ... made his vaccine by secretly relying on a technique used by a rival, Jean-Joseph Toussaint. Eventually, Pasteur's oxygen method did produce an anthrax vaccine, but only after he had won a monopoly to produce the vaccine.
Note: For more on how scientific myths are perpetuated, see this fascinating article. For more along these lines, see concise summaries of deeply revealing news articles on corruption in science from reliable major media sources.
Just last month, the World Health Organization announced that two of three strains of polio had been eradicated. It's been one of the great success stories of modern medicine. The disease, which, of course, can lead to paralysis, has been reduced to just a handful of cases around the world. But now scientists say there's been a troubling setback. One of the vaccines used to prevent polio has actually been causing some people to get polio. The problem begins with what's called a live vaccine, which has little bits of weakened polio virus in it, given to children around the world. What seems to have gone wrong? The oral polio vaccine that's used primarily in low- and middle-income countries - it's been the workhorse of this global effort to eradicate polio. But it is a live vaccine. It's cheap. It's easy to administer. However, this live vaccine is continued to be used worldwide. And while you're doing that, some of that vaccine has gotten out into the world. And it's mutated. It starts circulating again, just like regular polio. But early on, it's just - it's still a vaccine. It's not dangerous. And then slowly, it sort of regains strength. And they're finding they can actually genetically see this - that scientists can actually trace it back directly to the vaccine. And now these vaccine-linked cases are actually causing more cases of paralysis each year than actual traditional - what scientists call wild polio. In the United States and in Europe ... we're using an injectable vaccine, which is a dead vaccine. It is not a live virus, and it cannot cause polio.
Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Birth rates per 1000 females aged 25–29 fell from 118 in 2007 to 105 in 2015. One factor may involve the vaccination against the human papillomavirus (HPV). Shortly after the vaccine was licensed, several reports of recipients experiencing primary ovarian failure emerged. This study analyzed information gathered in National Health and Nutrition Examination Survey, which represented 8 million 25-to-29-year-old women residing in the United States between 2007 and 2014. Approximately 60% of women who did not receive the HPV vaccine had been pregnant at least once, whereas only 35% of women who were exposed to the vaccine had conceived. For married women, 75% who did not receive the shot were found to conceive, while only 50% who received the vaccine had ever been pregnant. The probability of having been pregnant was estimated for females who received an HPV vaccine compared with females who did not receive the shot. Results suggest that females who received the HPV shot were less likely to have ever been pregnant than women in the same age group who did not receive the shot. If 100% of females in this study had received the HPV vaccine, data suggest the number of women having ever conceived would have fallen by 2 million. Further study into the influence of HPV vaccine on fertility is thus warranted.
Note: Read an article on how this information is being suppressed by both government and industry. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and vaccine controversies.
President Trump recently selected Robert F. Kennedy Jr., a prominent vaccine skeptic who believes that shots may cause autism, to chair a panel on the safety of vaccines. The appointment has provoked howls of outrage from public health officials. Unfortunately, in their zeal to defend the benefits of vaccines, these advocates have pushed a narrative that vaccines are without risk. Every year, thousands of Americans receive vaccinations and then suffer a host of well-recognized reactions, ranging from chronic pain to paralysis. A 30-year-old federal program - meant to encourage vaccinations - compensates these patients for their medical costs and suffering. Unlucky patients who have terrible reactions to vaccines can seek compensation for their lost wages, medical bills and suffering through the National Vaccine Injury Compensation Program. Established in 1986, the vaccine program [grants] vaccine makers and doctors immunity from lawsuits. One of the most common vaccines, the flu shot, can trigger Guillain-Barré syndrome. Each year, as many as 6,000 Americans contract the disease, which causes an individual’s immune system to attack its own nerve cells. Persons diagnosed with the syndrome ... may experience permanent nerve damage, respiratory failure, or even death. Instead of seeking compensation from drugmakers, vaccine-injured patients can file a claim with the U.S. Court of Federal Claims. The program has awarded 5,269 victims more than $3.5 billion to date out of 17, 935 petitions filed.
Note: Robert F. Kennedy is highly respected for his great work as a lawyer defending the environment and much more. Yet now that he is challenging the safety of vaccines, most of the media are making him out to be a kook. If you want to understand why he is a threat to big pharma, which has a lot of control over the media, read Kennedy's excellent article "Deadly Immunity." For more along these lines, see concise summaries of deeply revealing vaccine news articles from reliable major media sources.
Robert De Niro and Robert F. Kennedy Jr. are looking for proof that vaccines are safe. The unlikely duo teamed up to offer $100,000 to anyone who can provide proof. “On one hand, the government is telling pregnant women which mercury-laced fish to avoid so that they don’t harm their fetuses, and on the other, the CDC supports injecting mercury-containing vaccines into pregnant women, infants and children,” Kennedy said at a joint press conference Wednesday. “This defies all logic and common sense.” De Niro, whose son has autism, and Kennedy specifically called out the use of thimerosal, which contains mercury. An FDA study in 1999 found that thimerosal used as a vaccine preservative posed no harm except for hypersensitivity. Despite that, the FDA phased the preservative out of vaccines for children and hasn’t been used since 2001, according to the Center for Disease Control. De Niro and Kennedy apparently don’t find that satisfactory and are offering a large cash reward, through Kennedy’s World Mercury Project, for anyone “who can find a peer-reviewed scientific study demonstrating that thimerosal is safe in the amounts contained in vaccines currently being administered to American children and pregnant women.” Kennedy, the son of the late Robert Kennedy and the nephew of the late John F. Kennedy, has long warned of the dangers of vaccines, [and] said recently that President Trump still wants him to chair a commission on vaccine safety and scientific integrity, which was proposed in early January when he met with the then-President Elect at Trump Tower.
Note: For more, see the World Mercury Project website. The major media consistently slams almost any news questioning the safety of vaccines, despite the fact that the US government's Health Resources & Services Administration website on this webpage states, "Since 1988, over 17,835 petitions have been filed with the VICP [Vaccine Injury Compensation Program]. Over that 27- year time period, 16,113 petitions have been adjudicated, with 5,205 of those determined to be compensable. Total compensation paid over the life of the program is approximately $3.5 billion." Why isn't that $3.5 billion price tag for compensation of vaccine injury being talked about?
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.